"One-shot" combined therapy with oral ivermectin and local benzyl benzoate: is the current best therapeutic option in the era of permethrin resistant scabies?

Travel Med Infect Dis. 2023 May-Jun:53:102585. doi: 10.1016/j.tmaid.2023.102585. Epub 2023 May 5.

Authors

Andrea Bassi¹, Vincenzo Piccolo², Carlo Mazzatenta³

Affiliations

¹ Division of Dermatology, Azienda USL Toscana Nord Ovest, Lucca, Italy. Electronic address: bassiderma@gmail.com.
² Dermatology Unit, University of Campania Luigi Vanvitelli, Naples, Italy.
³ Division of Dermatology, Azienda USL Toscana Nord Ovest, Lucca, Italy.

PMID: 37149241
DOI: 10.1016/j.tmaid.2023.102585

No abstract available

Keywords: Permethrin; Scabies; Therapy.

Publication types

Letter

MeSH terms

Administration, Oral
Benzoates / therapeutic use
Humans
Ivermectin* / therapeutic use
Permethrin / therapeutic use
Scabies* / drug therapy

Substances

Ivermectin
Permethrin
benzyl benzoate
Benzoates